Credit Corp has ceased discussions regarding its proposal to acquire 100% of Humm Group. The withdrawal follows a material reduction in the bid price after commercial due diligence investigations. The ...
Accendra Health (NYSE:ACH) reported first-quarter 2026 results that met internal expectations as the company nears the finish line of its transformation into a specialized home-based care provider.
Oracle (NYSE:ORCL) reported record fourth-quarter and full-year 2026 financial results, with broad-based growth across its Cloud Infrastructure and Cloud Applications businesses. Total Q4 revenues ...
UnitedHealth Group (NYSE:UNH) today reported financial results for the first quarter of 2026, delivering growth across its primary business platforms and raising its full-year earnings outlook. The ...
Netflix (NASDAQ:NFLX) reported first-quarter 2026 results that showcased resilient top-line momentum but raised concerns regarding near-term profitability and guidance. The streaming giant generated ...
Coronado Global Resources (ASX:CRN) has finalised an agreement to divest 100% of its interest in the Logan Mining Complex, located in West Virginia, USA. The Australian-listed coal producer will sell ...
The federal government is set to unveil a sweeping overhaul of negative gearing, capital gains tax, and trust distributions. The centrepiece of the reform is a strategic wind-back of negative gearing, ...
A Los Angeles County Superior Court jury has ordered Johnson & Johnson (NYSE:JNJ) to pay $32 million to the family of a California woman who died from pleural mesothelioma, concluding that her fatal ...
A Bitcoin holder posting as cprkrn on X said Anthropic’s Claude AI helped recover 5 Bitcoin from a wallet locked for more than 11 years after analysing files from an old college computer. The user ...
Oracle (NYSE:ORCL) delivered third-quarter fiscal 2026 results on Tuesday that exceeded Wall Street expectations, bolstered by a massive wave of demand for its artificial intelligence (AI) cloud ...
Accent Group (ASX:AX1) updated the market on a challenging second half for the 2026 financial year, citing a downturn in consumer sentiment and an ongoing investigation by the Australian Securities ...
Krystal Biotech (NASDAQ:KRYS) reported robust financial results for the first quarter of 2026, highlighted by continued commercial momentum for VYJUVEK, the first and only redosable gene therapy for ...